Skip to main content
. 2017 Sep 13;24:64–75. doi: 10.1016/j.ebiom.2017.09.010

Table 1.

Rare IRX3 variants were enriched in young obese subjects in comparison to lean controls.

Ntotal (male) Age (yrs)
BMI (kg/m2)
RareIRX3variant
Median (inter-quartile range) Range Median(inter-quartile range) Range N(%) OR (95% CI) Pvalue
Stage 1
 Cases 227 (98) 21 (18, 25) 13.0–30.0 38.4 (36.8, 41.2) 35.0–61.7 5 (2.20) 0.061
 Controls 219 (92) 38.4 (36.8, 41.2) 13.0–30.0 20.4 (19.5, 21.6) 17–23.0 0 (0)
Stage 2
 Cases 634 (262) 22 (18, 26) 12.0–30.0 34.6 (32.9, 37.3) 30.0–63.3 14 (2.21) 1.73 (0.74, 4.02) 0.20
 Controls 697 (244) 25 (22, 28) 14.0–58.0 19.5 (18.3, 21.0) 17.5–23.0 9 (1.29)
Combined
 Cases 861 (360) 22 (18, 25) 12.0–30.0 35.9 (33.6, 38.9) 30.0–63.3 19 (2.21) 2.27 (1.02, 5.05) 0.038
 Controls 916 (336) 24 (21, 27) 13.0–58.0 19.8 (18.6, 1.1) 17.5–23.0 9 (0.98)

N, sample size; Yrs, years; BMI, body mass index; OR, odds ratio; CI, confidence interval.

P values were calculated using χ2 tests.